Common use of Clinical Samples Clause in Contracts

Clinical Samples. In accordance with the Protocol, the Clinical Centre shall send clinical samples to the University (or, in accordance with clause 13.4 below, to a third party nominated by the University) for analysis. These clinical samples may include material, other than gametes, which consists of or includes human cells, but does not include embryos outside the human body, or hair and nail from the body of a living person (“Clinical Samples”). The Clinical Centre warrants that all Clinical Samples have been collected with appropriate informed consent and in accordance with applicable law (including without limitation the Human Tissue ▇▇▇ ▇▇▇▇ and the Human Tissue (Scotland) ▇▇▇ ▇▇▇▇ as appropriate). The Clinical Centre shall indemnify the University against any claims which may arise from the improper collection and supply of such Clinical Samples. The University shall use the Clinical Samples in accordance with the Protocol and the ethical approval for the Study, and shall ensure that the Clinical Samples are stored in accordance with applicable law, and that any Clinical Samples remaining at the end of the Study are either disposed of in accordance with the Human Tissue Authority guidelines and any applicable law or, if consent has been given for Clinical Samples to be used in further research, shall ensure that the Clinical Samples are transferred either to a licensed bio-repository or to another ethically approved study. The University may also arrange for Clinical Samples to be passed to a third party laboratory for analysis under a suitable agreement. If Clinical Samples are passed to a third party, the University shall ensure that the Clinical Samples are used, stored and disposed of in accordance with applicable law. The University shall indemnify the Clinical Centre against any claims arising from the improper use or storage of such Clinical Samples. This indemnity extends to use or storage by a third party as envisaged under clause 13.4 above.